← back to the state act
Inception date: 01 Nov 2009 | Removal date: open ended

Production subsidy

The Ministry Decree from 23 October 2009 # 965 the strategy of pharmaceutical industry development up to 2020 was proved. It is aimed at increasing the competitiveness of the domestic pharma industry. The strategy has the following benchmarks:

  • Increase of domestic products share in the internal market consumption up to 50 % (in value terms) by 2020.
  • Change of assortment of medications sold in Russia, including increase of innovative products number up to 60 % in value terms.
  • Increase of pharmaceutical products export by 8 times compared to 2008.
  • Provision of medicinal safety of Russia in compliance with the list of strategic medications and vaccines.
  • Stimulation of establishing pharmaceutical substances productions on the Russian territory in the volumes necessary for output of 50 % of finished substances (in money terms), including no less 85% by assortment of the list of strategic medications.

The benchmarks are to be achieved through:
1. Stimulation of localization on the Russian territory of high technology production of medicines.
2. Stimulation of establishing production of high technology chemical and biochemical substances in Russia.
3. Stimulation of obligatory transition of the domestic pharmaceutical manufacturers to Good Manufacturing Practice (GMP) standards by 2011.
4. Stimulation of development and production of generic and innovative medicines.
5. Elaboration of new educational programmes and modification of existing ones in order to enhance staff qualification and provide the pharmaceutical industry with new specialists.
6. Provision of medicinal safety of the Russian Federation.
The total finance of the programme for 2009-2020 makes 177 620 mln. roubles (6 billion US dollars).




352 Pharmaceutical products
3001 Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or
300190 Other
3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micr
300210 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
300220 Vaccines for human medicine
300230 Vaccines for veterinary medicine
300290 Other
3003 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.
300390 Other
3004 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packin
300410 Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives
300420 Containing other antibiotics
300431 Containing insulin
300432 Containing corticosteroid hormones, their derivatives or structural analogues
300439 Other
300440 Containing alkaloids or derivatives thereof but not containing hormones, other products of heading 29.37 or antibiotics
300450 Other medicaments containing vitamins or other products of heading 29.36
300490 Other
3005 Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
300510 Adhesive dressings and other articles having an adhesive layer
300590 Other
3006 Pharmaceutical goods specified in Note 4 to this Chapter.
300610 Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dent
300620 Bloodgrouping reagents
300630 Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient
300640 Dental cements and other dental fillings; bone reconstruction cements
300660 Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides
369 Other plastics products
3006 Pharmaceutical goods specified in Note 4 to this Chapter.
300691 Appliances identifiable for ostomy use

Please report this page in case you detect an inaccuracy in its content.